Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 3
2011 5
2012 4
2013 8
2014 13
2015 21
2016 35
2017 33
2018 42
2019 37
2020 32
2021 43
2022 32
2023 21
Text availability
Article attribute
Article type
Publication date

Search Results

294 results
Results by year
Filters applied: . Clear all
Page 1
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.
Wang Z, Ren J, Du J, Wang H, Liu J, Wang G. Wang Z, et al. Int J Mol Sci. 2022 Dec 17;23(24):16116. doi: 10.3390/ijms232416116. Int J Mol Sci. 2022. PMID: 36555754 Free PMC article. Review.
However, over the past few years, increasing evidence has shown that niclosamide could treat diseases beyond parasitic diseases, which include metabolic diseases, immune system diseases, bacterial and viral infections, asthma, arterial constriction, myopia, and cancer
However, over the past few years, increasing evidence has shown that niclosamide could treat diseases beyond parasitic diseases, whic …
Niclosamide: Beyond an antihelminthic drug.
Chen W, Mook RA Jr, Premont RT, Wang J. Chen W, et al. Cell Signal. 2018 Jan;41:89-96. doi: 10.1016/j.cellsig.2017.04.001. Epub 2017 Apr 4. Cell Signal. 2018. PMID: 28389414 Free PMC article. Review.
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies have indicated that niclosamide may have broad clinical applications for the treatment of diseases other than those caused by parasi
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. Drożdżal S, et al. Drug Resist Updat. 2021 Dec;59:100794. doi: 10.1016/j.drup.2021.100794. Epub 2021 Dec 9. Drug Resist Updat. 2021. PMID: 34991982 Free PMC article. Review.
Lastly, we summarize the studies on various drugs with incoherent or insufficient data concerning their effectiveness, such as amantadine, ivermectin, or niclosamide....
Lastly, we summarize the studies on various drugs with incoherent or insufficient data concerning their effectiveness, such as amantadine, i …
Niclosamide's potential direct targets in ovarian cancer†.
Sekulovski N, MacLean JA, Bheemireddy SR, Yu Z, Okuda H, Pru C, Plunkett KN, Matzuk M, Hayashi K. Sekulovski N, et al. Biol Reprod. 2021 Aug 3;105(2):403-412. doi: 10.1093/biolre/ioab071. Biol Reprod. 2021. PMID: 33855343 Free PMC article.
Recent evidence indicates that niclosamide is an anti-cancer compound that is able to inhibit several signaling pathways. Although niclosamide has previously been identified by high-throughput screening platforms as a potential effective compound against seve …
Recent evidence indicates that niclosamide is an anti-cancer compound that is able to inhibit several signaling pathways. Alth …
New insights into niclosamide action: autophagy activation in colorectal cancer.
Newton PT. Newton PT. Biochem J. 2019 Mar 6;476(5):779-781. doi: 10.1042/BCJ20190020. Biochem J. 2019. PMID: 30842311 Review.
Amongst the most promising new therapies, niclosamide-an FDA-approved drug for treating tapeworm infections-is being assessed in a stage II clinical trial for the treatment of metastatic colorectal cancer. ...This finding provides a further understanding of the acti …
Amongst the most promising new therapies, niclosamide-an FDA-approved drug for treating tapeworm infections-is being assessed in a st …
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities.
Barbosa EJ, Löbenberg R, de Araujo GLB, Bou-Chacra NA. Barbosa EJ, et al. Eur J Pharm Biopharm. 2019 Aug;141:58-69. doi: 10.1016/j.ejpb.2019.05.004. Epub 2019 May 9. Eur J Pharm Biopharm. 2019. PMID: 31078739 Review.
Drug repositioning may be defined as a process when new biological effects for known drugs are identified, leading to recommendations for new therapeutic applications. Niclosamide, present in the Model List of Essential Medicines, from the World Health Organization, has be …
Drug repositioning may be defined as a process when new biological effects for known drugs are identified, leading to recommendations for ne …
Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug.
Ren J, Wang B, Wu Q, Wang G. Ren J, et al. Biomed Pharmacother. 2022 Nov;155:113789. doi: 10.1016/j.biopha.2022.113789. Epub 2022 Oct 8. Biomed Pharmacother. 2022. PMID: 36271567 Free article. Review.
Niclosamide is a drug used to treat parasitic infections. Recent studies have shown that niclosamide may have a wide range of clinical applications and can be used to treat cancer and other diseases. ...This review summarizes the drug combination strategies a
Niclosamide is a drug used to treat parasitic infections. Recent studies have shown that niclosamide may have a wide range of
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.
Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ. Li Y, et al. Cancer Lett. 2014 Jul 10;349(1):8-14. doi: 10.1016/j.canlet.2014.04.003. Epub 2014 Apr 13. Cancer Lett. 2014. PMID: 24732808 Free PMC article. Review.
A number of studies have established the anticancer activities of niclosamide in both in vitro and in vivo models. Moreover, the inhibitory effects of niclosamide on cancer stem cells provide further evidence for its consideration as a promising drug for c
A number of studies have established the anticancer activities of niclosamide in both in vitro and in vivo models. Moreover, the inhi …
Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy.
Ma R, Ma ZG, Gao JL, Tai Y, Li LJ, Zhu HB, Li L, Dong DL, Sun ZJ. Ma R, et al. J Biomed Mater Res A. 2020 Jan;108(1):30-38. doi: 10.1002/jbm.a.36788. Epub 2019 Sep 5. J Biomed Mater Res A. 2020. PMID: 31433913
Niclosamide is an antihelminthic drug. Recent studies show that niclosamide exerts antitumor activity through inhibiting multiple signals including Wnt/beta-catenin, mTORC1, signal transducer and activator of transcription 3, NF-kappaB, notch signals; however, the i
Niclosamide is an antihelminthic drug. Recent studies show that niclosamide exerts antitumor activity through inhibiting multi
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim H, Yin T, Fan S, Shen Q. Lu L, et al. Oncogene. 2018 Sep;37(39):5292-5304. doi: 10.1038/s41388-018-0340-y. Epub 2018 May 31. Oncogene. 2018. PMID: 29855616
Radiotherapy significantly improves the therapeutic outcomes and survival of breast cancer patients. However, the acquired resistance to this therapeutic modality is a major clinical challenge. ...Moreover, knockdown of STAT3 by shRNA sensitized the TNBC cells to IR. Ni
Radiotherapy significantly improves the therapeutic outcomes and survival of breast cancer patients. However, the acquired resistance …
294 results